Nontuberculous Mycobacteria–associated Lung Disease in Hospitalized Persons, United States, 1998–2005
Megan E. Billinger, Kenneth N. Olivier, Cecile Viboud, Ruben Montes de Oca, Claudia Steiner, Steven M. Holland, and D. Rebecca Prevots
Author affiliations: George Washington University, Washington, DC, USA (M.E. Billinger); National Institutes of Health, Bethesda, Maryland, USA (K.N. Olivier, C. Viboud, R. Montes de Oca, S.M. Holland, D.R. Prevots); Agency for Healthcare Research and Quality, Rockville, Maryland, USA (C. Steiner)
Figure 7. Prevalence of bronchiectasis as a secondary diagnosis by age group and sex when non-AIDS pulmonary nontuberculous mycobacteria is the primary diagnosis, Healthcare Cost and Utilization Project state inpatient databases, USA, 1998–2005.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.